4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Ab&B Bio-Tech CO., LTD. JS (2627) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Taizhou, China with about 583 employees. Its market capitalization is roughly CNY 12 billion. In the fiscal year ended 2024-12-31, 2627 reported CNY 260M in revenue and (CNY 259M) in net income.
Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.
Interactive charts & full statements →
| Income statement | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total Revenue | CNY 260M | CNY 52M |
| Gross Profit | CNY 152M | (CNY 20M) |
| Operating Income (EBIT) | (CNY 229M) | (CNY 423M) |
| Net Income | (CNY 259M) | (CNY 425M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-06-30 | 2025-03-31 |
|---|---|---|
| Total Revenue | CNY 71M | CNY 0M |
| Gross Profit | CNY 64M | (CNY 4M) |
| Operating Income (EBIT) | (CNY 30M) | (CNY 76M) |
| Net Income | (CNY 34M) | (CNY 87M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total Assets | CNY 1.6B | CNY 1.1B |
| Total Liabilities | CNY 1.5B | CNY 756M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2627 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms